The expression of complements C1R, C1S, C2, C5, CFB, CFI, C8A, C9, CR4 (ITGAX), C5aR1, C1INH, C4BPA, C4BPB, CLU, CD46, CD55, CPN1, CRIg, and C1qR was significantly higher in CRC samples, while the expression of complements C1S, C3, C6, C7, C8B, CFD, CFP, CFHR1, CFHR2, CFHR3, CR1, CR2, CR3 (ITGAM), C3aR1, C1INH, MASP2, MASP1, CLU, CD55, CD59, CRIg, C1qR, and SIGN1 was lower in CRC samples than that in normal tissues. This evidence concerns the gene CR2 and colorectal carcinoma.